A Nova Conformação Setorial da Indústria Farmacêutica Mundial: redesenho nas pesquisas e ingresso de novos atores

• Autor(a) principal: Radaelli, Vanderléia
• Data de Publicação: 2008
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Brasileira de Inovação (Online)
• Texto Completo: https://periodicos.sbu.unicamp.br/ojs/index.php/rbi/article/view/8648971
• topic: Pharmaceutical Industry; Research and Development Science based; News Biotechnology Firms; L16; L25; L65; Indústria farmacêutica. Pesquisa e desenvolvimento baseado em ciência. Novas empresas de biotecnologia.; L16; L25; L65

This paper presents the most important cycles related to the pharmaceutical sector’s emergence, pointing out the main intra-industry links that, by letting firms benefit from the expansion opportunities, contributed to the consolidation of the sector in national, regional, and global terms. The main pharmaceutical industry’s evolutionary cycles are discussed. For each one, economic factors exogenous to the industry are presented. Those factors, combined with the biggest firms’ goals, led to scientific advances. Such advances, along with commercial and financial revenues and asset establishment, were concentrated in the big companies, granting them competitive advantages and innovative leadership in the sector. At the end are presented consequences for the value chain of the last evolutive cycle of pharmaceutical industry. New institutions and new forms of research had increased its importance to allow the entry of actors in the sectoral system, an unthinkable fact in previous cycles.